Asia Insurance Post
  • Home
  • Articles
  • Blog
  • Data
  • Facts
  • Editorial
  • Interviews
Select Page

US Cap on drug price hikes for privately insured sparks battle

by AIP Online Bureau | Nov 21, 2021 | Eco/Invest/Demography, Health, International News, Non-Life, Policy, Regulation

Polls show that Americans across the political spectrum overwhelmingly favor government action to reduce drug prices. The chief cost complaints are: high out-of-pocket costs for patients, high and rising list prices, and high launch prices for new medicines. The Biden...

Recent Posts

  • IUAI establishes new Reinsurance and Data Study Group to strengthen industry knowledge and expertise
  • Drugmakers tap China AI app boom to reach doctors as crackdown upends marketing
  • Star Health urges Delhi NCR families to take precautions as Air Quality stays poor; Home health care use up 4.4x
  • LIC, Coforge, Adani Green, Meesho enter MSCI Global Standard Index; India’s weight rises to 13.1%
  • US-Iran war to cost Gulf states $790 billion until 2030: Allianz Trade

Categories

  • Articles
  • Banking & Bancassurance
  • Blog
  • Breaking News!
  • Briefs
  • Climate, Environment, Renewable Energy
  • Data
  • Disaster & Management
  • Eco/Invest/Demography
  • Editorial
  • Events
  • Facts
  • Features
  • Health
  • Indian News
  • Intermediaries
  • International News
  • Interviews
  • Life
  • Main Menu
  • Non-Life
  • Pandemic
  • Pension & Social Security
  • Policy
  • Regulation
  • Reinsurance
  • Risk Management
  • Simple
  • Technology
  • Trends, Facts
  • Uncategorized
  • Wealth Management/ Philanthropy
  • Workplace/Employee Benefits
  • Home
  • Articles
  • Blog
  • Data
  • Facts
  • Editorial
  • Interviews
  • Eco/Invest/Demography
  • Indian News
  • International News
  • Health
  • Non-Life
  • Pandemic
  • Technology
  • Risk Management
  • Reinsurance
  • Banking & Bancassurance
  • Wealth Management/ Philanthropy